We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+5.3%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$342B
AUM Growth
+$4.99B
Cap. Flow
-$5.86B
Cap. Flow %
-1.71%
Top 10 Hldgs %
31.71%
Holding
3,487
New
211
Increased
1,344
Reduced
1,316
Closed
159

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.03B
2
VLO icon
Valero Energy
VLO
+$273M
3
PGR icon
Progressive
PGR
+$259M
4
AMD icon
Advanced Micro Devices
AMD
+$256M
5
ORLY icon
O'Reilly Automotive
ORLY
+$232M

Sector Composition

Rank Sector Weight
1 Technology 31.78%
2 Financials 11.71%
3 Healthcare 11.09%
4 Consumer Discretionary 10.64%
5 Communication Services 8.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FDMT icon
2226
4D Molecular Therapeutics
FDMT
$562M
$2.59M ﹤0.01%
123,468
+14,718
+14% +$369K
UNIT
2227
Uniti Group
UNIT
$2.32B
$2.59M ﹤0.01%
885,504
-242
-0% -$1.01K
PSTL
2228
Postal Realty Trust
PSTL
$699M
$2.57M ﹤0.01%
193,060
-4,666
-2% -$63.3K
QS icon
2229
QuantumScape Corp
QS
$3.74B
$2.57M ﹤0.01%
521,880
-111,305
-18% -$621K
AVNS
2230
DELISTED
Avanos Medical
AVNS
$2.56M ﹤0.01%
128,365
AXGN icon
2231
Axogen
AXGN
$2.5B
$2.56M ﹤0.01%
353,136
IBRX icon
2232
ImmunityBio
IBRX
$8.1B
$2.55M ﹤0.01%
403,528
-102,897
-20% -$678K
GRC icon
2233
Gorman-Rupp
GRC
$2.21B
$2.55M ﹤0.01%
69,428
RCUS icon
2234
Arcus Biosciences
RCUS
$3.64B
$2.55M ﹤0.01%
167,301
+40,082
+32% +$647K
NWLI
2235
DELISTED
National Western Life Group, Inc. Class A
NWLI
$2.54M ﹤0.01%
5,121
+287
+6% +$141K
IQ icon
2236
iQIYI
IQ
$1.28B
$2.54M ﹤0.01%
692,486
+52,900
+8% +$239K
ANIK icon
2237
Anika Therapeutics
ANIK
$287M
$2.53M ﹤0.01%
100,076
-96,100
-49% -$2.49M
STOK icon
2238
Stoke Therapeutics
STOK
$2.11B
$2.53M ﹤0.01%
187,351
+67,540
+56% +$912K
TRNS icon
2239
Transcat
TRNS
$871M
$2.53M ﹤0.01%
21,103
+567
+3% +$67K
IRON icon
2240
Disc Medicine
IRON
$2.97B
$2.52M ﹤0.01%
55,921
+16,316
+41% +$554K
MTUS icon
2241
Metallus
MTUS
$898M
$2.51M ﹤0.01%
124,022
-31,345
-20% -$686K
DHC
2242
Diversified Healthcare Trust
DHC
$2.14B
$2.5M ﹤0.01%
820,378
+91,451
+13% +$232K
CXM icon
2243
Sprinklr
CXM
$1.61B
$2.49M ﹤0.01%
259,167
-614,754
-70% -$6.87M
MEOH icon
2244
Methanex
MEOH
$4.12B
$2.49M ﹤0.01%
51,550
NX icon
2245
Quanex
NX
$1.01B
$2.49M ﹤0.01%
89,972
+2,944
+3% +$97.4K
INST
2246
DELISTED
Instructure Holdings, Inc.
INST
$2.49M ﹤0.01%
106,229
+47,308
+80% +$1.01M
INDI icon
2247
indie Semiconductor
INDI
$854M
$2.48M ﹤0.01%
401,947
+18,187
+5% +$116K
JACK icon
2248
Jack in the Box
JACK
$335M
$2.48M ﹤0.01%
48,648
+462
+1% +$25.9K
ARKO icon
2249
ARKO Corp
ARKO
$635M
$2.48M ﹤0.01%
394,873
+121,709
+45% +$654K
LZ icon
2250
LegalZoom.com
LZ
$988M
$2.47M ﹤0.01%
294,459
-422,623
-59% -$4.35M

Similar funds

Nuveen's Q2 2024 Portfolio in Review

As of Q2 2024, Nuveen held 3,487 positions worth $342B, up 1.5% from $337B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Nuveen's Q2 2024 filing shows 211 new, 1,344 increased, 1,316 reduced and 159 closed positions. Its largest new stake was GE Vernova: 595,802 shares worth $102M. The largest sale was Meta Platforms (Facebook), an estimated $466M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q2 2024 buy was GE Vernova: 595,802 shares worth $102M.
  • Nuveen added most to Apple in Q2 2024, an estimated $1.03B increase.
  • Nuveen's biggest Q2 2024 reduction was Meta Platforms (Facebook), cutting an estimated $466M.
  • Nuveen fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $389M.
  • Nuveen's ten largest holdings make up 32% of its $342B portfolio in Q2 2024.
  • Nuveen opened 211 new positions and closed 159 in Q2 2024.
  • Nuveen's portfolio value rose 1.5% quarter-over-quarter to $342B.

Based on Nuveen's 13F filing for Q2 2024, filed 9 Aug 2024.